03906nam 2201021z- 450 991034684090332120231214133429.03-03921-192-7(CKB)4920000000095231(oapen)https://directory.doabooks.org/handle/20.500.12854/52779(EXLCZ)99492000000009523120202102d2019 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierMarine Natural Products and ObesityMDPI - Multidisciplinary Digital Publishing Institute20191 electronic resource (194 p.)3-03921-191-9 Obesity and related co-morbidities are increasing worldwide and pose a serious health problem. Changes in lifestyle and diet would be the best remedies to fight obesity; however, many people will still rely on medical aid. Marine organisms have been prolific in the production of bioactive compounds for many diseases, e.g., cancer, and promise to be an excellent source for natural-derived molecules and novel nutraceuticals. Bioactive compounds with beneficial activities towards obesity have been described from diverse marine organism including marine algae, bacteria, sponges, fungi, crustaceans or fish. This Special Issue will highlight the progress in the following topics: Bioactive compounds for the treatment of obesity and obesity-related co-morbidities (diabetes, fatty liver, hyperlipidemia) from marine organisms; the isolation of novel compounds, the bioactivity screening of marine organisms and the elucidation of molecular mode of action of marine bioactive compounds.natural compoundsanti-obesity drugshigh fat dietIshige okamuraefatzebrafish Nile red fat metabolism assayphysical exerciseJAK2-STAT3metabolite profilingobesitychlorophyll derivativesbrown seaweedSkate skinPPAR?marine algamarine biodiscoveryskate skinlipolyticleptinuncoupling protein 13T3-L1 cellsglucolipid metabolism disordernutritionbioactivitychitosan oligosaccharidediphlorethohydroxycarmalol (DPHC)nutraceuticalswhole small animal modelshigh-fat dietadipocytedyslipidemiabioactivity screeningperoxisome proliferator-activated receptor gammawhite adipose tissueantiobesityfatty liver diseasethermal proteome profilinginflammationcyanobacteriaRaja kenojeiArthrospira maximacellularityadipocytesbioactive compoundcollagen peptidedouble-blindbisabolane-related compoundsproliferationfatty acid metabolismcholesterol metabolismcollagenrandomized controlled trialmechanisms of actionmurine pre-adipocytesadipogenesisfucanmarine spongeslabel-free quantitative proteomicsdiabetesbody fatVasconcelos Vítorauth1301488Urbatzka RalphauthBOOK9910346840903321Marine Natural Products and Obesity3033517UNINA